Login / Signup

Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials.

Akhil Deepak VatvaniAndree KurniawanTimotius Ivan Hariyanto
Published in: The Annals of pharmacotherapy (2023)
This study indicates that although safe, fluvoxamine was not effective for outpatient treatment of Covid-19. Until more evidence can be obtained from larger RCTs, our study did not encourage the use of fluvoxamine as routine management for patients with Covid-19.
Keyphrases
  • clinical trial
  • coronavirus disease
  • clinical practice
  • randomized controlled trial
  • open label
  • study protocol